Bentham Science Logo

Track Your Manuscript:


Current Drug Targets

Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Most Cited Articles

Review Article

Bioinformatics approaches for anti-cancer drug discovery

, 2020; 21(1): 3-17.

Kening Li, Yuxin Du, Lu Li and Dong-Qing Wei*


DOI: 10.2174/1389450120666190923162203



Review Article

ACE2/angiotensin-(1-7)/mas receptor axis in human cancer: Potential role for pediatric tumors

, 2020; 21(9): 892-901.

Ana Luiza Ataide Carneiro de Paula Gonzaga , Vitória Andrade Palmeira , Thomas Felipe Silva Ribeiro , Larissa Braga Costa , Karla Emília de Sá Rodrigues and Ana Cristina Simões-e-Silva *


DOI: 10.2174/1389450121666200210124217


Review Article

Targeting cancer stem cells pathways for the effective treatment of cancer

, 2020; 21(3): 258-278.

Ashish Ranjan Dwivedi, Amandeep Thakur, Vijay Kumar, Ira Skvortsova and Vinod Kumar*


DOI: 10.2174/1389450120666190821160730


Review Article (Mini-Review)

The therapeutic potential of chemokines in the treatment of chemotherapy-induced peripheral neuropathy

, 2020; 21(3): 288-301.

Lin Zhou, Luyao Ao, Yunyi Yan, Wanting Li, Anqi Ye, Yahui Hu*, Weirong Fang* and Yunman Li*


DOI: 10.2174/1389450120666190906153652



Review Article (Mini-Review)

Antiviral drug targets of single-stranded rna viruses causing chronic human diseases

, 2020; 21(2): 105-124.

Dhurvas Chandrasekaran Dinesh*, Selvaraj Tamilarasan, Kaushik Rajaram and Evžen Bouřa*


DOI: 10.2174/1389450119666190920153247



Review Article

Medicinal perspective of indole derivatives: Recent developments and structure-activity relationship studies

, 2020; 21(9): 864-891.

Devendra Kumar, Sahil Sharma, Sourav Kalra, Gurpreet Singh, Vikramdeep Monga and Bhupinder Kumar*


DOI: 10.2174/1389450121666200310115327



Review Article

The potential of pi3k/akt/mtor signaling as a druggable target for endometrial and ovarian carcinomas

, 2020; 21(10): 946-961.

Csongor György Lengyel*, Sara Cecilia Altuna, Baker Shalal Habeeb, Dario Trapani and Shah Zeb Khan


DOI: 10.2174/1389450120666191120123612


Review Article

IL-37 as a potential biotherapeutics of inflammatory diseases

, 2020; 21(9): 855-863.

Junhui Bai, Yukun Li, Meixiang Li, Sijie Tan* and Daichao Wu*


DOI: 10.2174/1389450121666200429114926


Review Article

Understanding the pharmaceutical aspects of dendrimers for the delivery of anticancer drugs

, 2020; 21(6): 528-540.

Sunil Kumar Dubey*, Shubham Salunkhe, Mukta Agrawal, Maithili Kali, Gautam Singhvi, Sanjay Tiwari, Swarnlata Saraf, Shailendra Saraf and Amit Alexander*


DOI: 10.2174/1389450120666191031092259


Review Article

Nanosized modification strategies for improving the antitumor efficacy of MEK inhibitors

, 2020; 21(3): 228-251.

Yanan Li, Qingrong Dong, Ting Mei, Meichen Zheng, Ramasamy Raj Kumar, Bin Yu, Chunsheng Wu, Hui Zhang* and Feifei An*


DOI: 10.2174/1389450120666190807143245


General Review Article

Advances in the treatment of ovarian cancer using PARP inhibitors and the underlying mechanism of resistance

, 2020; 21(2): 167-178.

Ling Wang, Qi Wang, Yangchun Xu, Manhua Cui and Liying Han*


DOI: 10.2174/1389450120666190925123507



Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog